With
the Ebola outbreak, various medical professionals turned to human plasma from
individuals that had survived Ebola as a source of combatting Ebola in infected
individuals. However, one of the problems with such approach is quantity of
plasma available. An American startup, Sioux Falls-based SAB Biotherapeutics,
however, has come up with a possible solution--genetically engineering cows to
become “plasma factories.”
The
way that the cows become engineered is that the scientist will knock out a
section of genes in the cows and replace them with a human artificial
chromosome that will allow for human antibody production. After the chromosome
is inserted, the cows will get vaccinated with a target disease antigen that
will help lead to the production of antibodies, which the scientists can then
collect to create a therapeutic drug. The cows will be able to produce between
300-1,000 more doses per month compared to a human, which could be very useful
for future health outbreaks.
While
the antibody production will take under 3 months, one of the main challenges
will be the cost. A gram of antibodies is around $2,000, which is a fairly
hefty price considering the target countries may tend to have weaker economies
than the US. However, the WHO has recognized this interesting approach as a
possible manner of responding to disease outbreaks so this may turn out to be
really effective in future health events.
--Jeanette
Rios
No comments:
Post a Comment